StreetInsider.com After-Hours Movers 09/19

StreetInsider.com After-Hours Movers:

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) 31% LOWER; announced preliminary findings from a Phase II study with intramuscular (i.m.) injection of peramivir, its candidate for the treatment of seasonal and life-threatening influenza. The company said the improvement over placebo was not statistically significant.

Monolithic Power Systems (Nasdaq: MPWR) 7.6% HIGHER; now expects third quarter revenue to be in the range of $38 million to $39 million. Prior revenue guidance for the third quarter was a range of $33 million to $35 million. The consensus is $34.3 million.

NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) 6% HIGHER; Said the FDA has granted orphan drug designation to PREOS for the treatment of hypoparathyroidism, a rare deficiency of parathyroid hormone for which there is no FDA-approved therapy.

CLARCOR Inc. (NYSE: CLC) 5% LOWER; reported Q3 EPS of $0.45, ex-gain, versus the consensus of $0.49. Revenues came in at $238.3 million versus the consensus of $248.7 million. Sees 2007 EPS of $1.66-$1.70, ex-gain, versus the consensus of $1.77.

Herman Miller Inc. (Nasdaq: MLHR) 4% LOWER; reports Q1 EPS of $0.54, 4 cents better than estimates. Revenues came in at $491.7 million versus the consensus of $489.7 million. Sees Q2 EPS of $0.51-$0.57, versus the consensus of $0.59. Sees Q2 sales of $475-$500 million versus the consensus of $519.6 million.

Radian Group Inc. (NYSE: RDN) 3.6% HIGHER; Continues today's 9% move higher following yesterday's rate cut. Sold a portion of its investment in Sherman Financial Group LLC to an entity owned by Sherman management.

You May Also Be Interested In

• After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
• After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
• Dutch Bros plummets on slowing sales, cut EBITDA outlook